Imprimis NJOF, LLC: Drug Recall

Recall #D-0535-2025 · 07/09/2025

Class II: Risk

Recall Details

Recall Number
D-0535-2025
Classification
Class II
Product Type
Drug
Recalling Firm
Imprimis NJOF, LLC
Status
Ongoing
Date Initiated
07/09/2025
Location
Ledgewood, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,880 vials

Reason for Recall

Sub-Potent Drug: Subpotent assay results during stability testing.

Product Description

Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01

Distribution Pattern

Nationwide in the USA

Other Recalls by Imprimis NJOF, LLC

View all recalls by Imprimis NJOF, LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.